Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1.
OCT1
SLC22A1
enhancement
inhibition
potentiation
transport
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Feb 2022
11 Feb 2022
Historique:
received:
21
01
2022
revised:
08
02
2022
accepted:
09
02
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
16
3
2022
Statut:
epublish
Résumé
The organic cation transporter 1 (OCT1,
Identifiants
pubmed: 35216120
pii: ijms23042007
doi: 10.3390/ijms23042007
pmc: PMC8878159
pii:
doi:
Substances chimiques
Octamer Transcription Factor-1
0
POU2F1 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 461080000
Organisme : Deutsche Forschungsgemeinschaft
ID : 437446827
Références
Nature. 2011 Aug 31;477(7362):54-60
pubmed: 21886157
Mol Pharmacol. 2005 May;67(5):1612-9
pubmed: 15662045
J Med Chem. 2019 Nov 14;62(21):9890-9905
pubmed: 31597043
Mol Pharmacol. 2019 Feb;95(2):169-182
pubmed: 30409791
Mol Pharmacol. 2018 Sep;94(3):1057-1068
pubmed: 29884691
Science. 2019 Jun 21;364(6446):1184-1188
pubmed: 31221859
Clin Pharmacol Ther. 2016 Jun;99(6):633-41
pubmed: 26659468
Drug Metab Dispos. 2020 Feb;48(2):93-105
pubmed: 31771949
Front Pharmacol. 2021 Jan 20;11:609811
pubmed: 33551812
Mol Pharmacol. 1999 Dec;56(6):1254-61
pubmed: 10570053
Neuropharmacology. 2006 Jun;50(8):941-52
pubmed: 16581093
Br J Clin Pharmacol. 2014 Dec;78(6):1426-32
pubmed: 25060604
Pharmacol Rev. 2020 Jan;72(1):253-319
pubmed: 31852803
PLoS One. 2017 Dec 13;12(12):e0189521
pubmed: 29236753
J Pharmacol Exp Ther. 2009 Apr;329(1):252-61
pubmed: 19141712
Drug Metab Dispos. 2007 Aug;35(8):1333-40
pubmed: 17496207
PLoS One. 2015 Sep 01;10(9):e0136451
pubmed: 26327616
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18825-30
pubmed: 19846789
Biol Chem. 2019 Jan 28;400(2):195-207
pubmed: 30138103
Drug Metab Dispos. 2020 Dec;48(12):1380-1392
pubmed: 33037045
Biochem Pharmacol. 2020 Jan;171:113731
pubmed: 31783011
J Med Chem. 2021 Mar 11;64(5):2762-2776
pubmed: 33606526
Clin Pharmacol Ther. 2012 Nov;92(5):661-5
pubmed: 23010651
Mol Pharmacol. 2009 Aug;76(2):275-89
pubmed: 19435783
Clin Pharmacol Ther. 2008 Feb;83(2):273-80
pubmed: 17609683
Eur J Pharm Sci. 2014 Nov 20;64:44-52
pubmed: 25169756
Pharmacogenomics. 2014 Jul;15(10):1297-309
pubmed: 25155932
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
PLoS Biol. 2018 Apr 16;16(4):e2002907
pubmed: 29659562
Clin Pharmacol Ther. 2020 Mar;107(3):628-638
pubmed: 31593619
J Med Chem. 2017 Apr 13;60(7):2685-2696
pubmed: 28230985
J Med Chem. 2008 Oct 9;51(19):5932-42
pubmed: 18788725
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Nature. 2016 Apr 21;532(7599):334-9
pubmed: 27049939
Hepatology. 2009 Oct;50(4):1227-40
pubmed: 19591196
Expert Opin Drug Metab Toxicol. 2021 Jun;17(6):635-653
pubmed: 33896325
Int J Mol Sci. 2021 Nov 26;22(23):
pubmed: 34884618
J Med Chem. 2013 Sep 26;56(18):7232-42
pubmed: 23984907
Clin Pharmacol Ther. 2018 May;103(5):868-878
pubmed: 28791698
Mol Pharmacol. 2005 May;67(5):1600-11
pubmed: 15662044
Ann Nutr Metab. 2016;68 Suppl 3:5-9
pubmed: 27931018
J Clin Pharmacol. 2020 Mar;60(3):312-323
pubmed: 31542894
AAPS J. 2014 Nov;16(6):1247-58
pubmed: 25155823
Eur J Pharmacol. 2010 May 25;634(1-3):1-9
pubmed: 20170649
Biochem Pharmacol. 2022 Mar;197:114871
pubmed: 34902340
Br J Pharmacol. 2002 Nov;137(6):910-8
pubmed: 12411423